| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.096 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |